Ubs Asset Management Americas Inc Accelerate Diagnostics, Inc Transaction History

Ubs Asset Management Americas Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.54 - $1.41 $18,125 - $47,328	-33,566 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $5,824 - $9,507	1,364 Added 4.24%	33,566 $175,000
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $1,731 - $2,689	326 Added 1.02%	32,202 $187,000
Q2 2021 Aug 16, 2021	BUY	$6.81 - $9.23 $6,299 - $8,537	925 Added 2.99%	31,876 $256,000
Q3 2020 Nov 13, 2020	BUY	$9.98 - $18.04 $159,190 - $287,756	15,951 Added 106.34%	30,951 $329,000
Q2 2020 Aug 14, 2020	SELL	$7.49 - $15.16 $78,195 - $158,270	-10,440 Reduced 41.04%	15,000 $227,000
Q1 2020 May 15, 2020	SELL	$4.62 - $18.74 $7,923 - $32,139	-1,715 Reduced 6.32%	25,440 $211,000
Q4 2019 Feb 14, 2020	SELL	$14.6 - $18.13 $934 - $1,160	-64 Reduced 0.24%	27,155 $458,000
Q3 2019 Nov 14, 2019	BUY	$16.62 - $23.92 $191,445 - $275,534	11,519 Added 73.37%	27,219 $505,000
Q2 2018 Aug 14, 2018	BUY	$19.02 - $24.95 $129,336 - $169,660	6,800 Added 76.4%	15,700 $0
Q4 2017 Feb 09, 2018	BUY	$18.0 - $30.0 $160,200 - $267,000	8,900	8,900 $0

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $168M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.